摘要
维生素D长时间以来一直是钙磷平衡以及随着甲状旁腺激素(PTH)动态平衡的主要因素。维生素D对钙和磷的影响是完全已知的,但最近的研究试图将维生素D的状态和心血管疾病联系起来。 维生素D重塑血管是由如肾素-血管紧张素-醛固酮系统(RAAS)的激活,细胞增殖和抗凋亡的细胞通路等多种机制所介导的。这种相关性可以被以下事实所突出,维生素D的活性形式(1,25(OH)2 D3)由于存在内皮1α-羟化酶的结构,因此可以通过相同的内皮细胞合成。维生素D降低了内皮细胞表面(AT2R)的血管紧张素2号受体(AT2R)的表达,产生了一系列事件,导致了如一氧化氮等血管扩张剂的合成。内皮细胞上的维生素D受体(VDR)的激活诱导了血管内皮细胞的代谢活动的变化,同时负责细胞存活、增殖和新生血管形成。此外,由于基因多态性的改变而引起的VDR信号已被证明可以治疗心脏疾病、慢性肾脏疾病(CKD)等。最近,血管通路的结果已经与维生素D状态联系起来了。未来的研究将有助于更好地定义心血管补充维生素D的必要性以及其与CKD患者血管通路的结果。
关键词: 动脉粥样硬化;内皮细胞;平滑肌细胞;血管通路;维生素D。
Current Medicinal Chemistry
Title:Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Volume: 23 Issue: 17
Author(s): Domenico Santoro, Vincenzo Pellicanò, Valeria Cernaro, Viviana Lacava, Antonio Lacquaniti, Marco Atteritano, Michele Buemi
Affiliation:
关键词: 动脉粥样硬化;内皮细胞;平滑肌细胞;血管通路;维生素D。
摘要: Vitamin D has been known for a long time as a major factor involved in the calcium- phosphate balance and homeostasis, along with parathyroid hormone (PTH). While vitamin D effects on calcium and phosphate are fully known, recent studies attempted to link vitamin D status and cardiovascular diseases.
The involvement of vitamin D on vascular remodeling is mediated by several mechanisms such as activation of renin-angiotensin-aldosterone system (RAAS), cell proliferation and anti-apoptotic cell pathways. This correlation is highlighted by the fact that the activated form of vitamin D (1,25 (OH)2 D3) can be synthesized by the same endothelial cells, due to the constitutive presence of endothelial 1α-hydroxylase. Vitamin D reduces the expression of angiotensin 2 receptor (AT2R) on the endothelial cell surface (AT2R), leading to a cascade of events that result in the synthesis of vasodilators, such as nitric oxide. The activation of vitamin D receptors (VDRs) on endothelial cells induces changes in the metabolic activity of the endothelium and is responsible for cell survival, proliferation and neoangiogenesis. Moreover, altered signaling of VDR due to gene polymorphisms has been demonstrated in patients with cardiac disorders and chronic kidney disease (CKD). Recently, vascular access outcome has been associated with vitamin D status. Future studies will help to better define the need of vitamin D supplementation for a better cardiovascular as well as vascular access outcome in patients with CKD.
Export Options
About this article
Cite this article as:
Domenico Santoro, Vincenzo Pellicanò, Valeria Cernaro, Viviana Lacava, Antonio Lacquaniti, Marco Atteritano, Michele Buemi , Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease, Current Medicinal Chemistry 2016; 23 (17) . https://dx.doi.org/10.2174/0929867323666160405112019
DOI https://dx.doi.org/10.2174/0929867323666160405112019 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Synthesis of Nano-Doxorubicin and its Anticancer Effect
Anti-Cancer Agents in Medicinal Chemistry Role of Immunostimulatory Molecules in Poultry Vaccines
Recent Patents on Biotechnology The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Current Topics in Medicinal Chemistry Targeting miRNAs for Pancreatic Cancer Therapy
Current Pharmaceutical Design Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
Recent Patents on Biotechnology Salinomycin: A Novel Anti-Cancer Agent with Known Anti-Coccidial Activities
Current Medicinal Chemistry Editorial (Thematic Issue: Oncoviruses and Head and Neck Cancer: An Impending Facts)
Recent Patents on Biomarkers Viral Inhibition of Tumour Necrosis Factor-α (TNFα) and TNF-Receptor Induced Apoptosis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Designing HIV Integrase Inhibitors-Shooting the Last Arrow
Current Medicinal Chemistry CORAL: Classification Model for Predictions of Anti-Sarcoma Activity
Current Topics in Medicinal Chemistry Collagenolytic Enzymes and their Applications in Biomedicine
Current Medicinal Chemistry Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy
Current Medicinal Chemistry Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews MicroRNAs: Potential Diagnostic and Therapeutic Targets for Breast Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Current Status of Anti-HIV Agents
Current Medicinal Chemistry - Anti-Infective Agents